申请人:HAMLYN Richard John
公开号:US20110136859A1
公开(公告)日:2011-06-09
A compound of formula (I)
Or its salts or pharmaceutically acceptable derivatives thereof wherein;
A represents a chemical moiety with the general formula (II):
X is selected from a group consisting of CH
2
, C(═O), CH(R
5
), C(R
5
)(R
6
) or C(R
5
)(R
6
)CH
2
;
R
1
is selected from the group consisting of optionally substituted arylalkyl, and optionally substituted heteroarylalkyl;
R
2
is selected from the group consisting of optionally substituted aryl or optionally substituted heteroaryl or NR
7
R
8
;
R
3
R
4
R
5
R
6
R
7
and R
8
are as defined herein; and n=1 or 2 is provided. Pharmaceutical compositions comprising the compounds are also provided. The compounds are useful in treating various conditions including arrhythmia.
化合物公式(I)或其盐或药学上可接受的衍生物,其中:A代表具有通式(II)的化学基团:X从以下组中选择:CH2,C(═O),CH(R5),C(R5)(R6)或C(R5)(R6)CH2;R1从以下组中选择:可选择取代的芳基烷基或可选择取代的杂芳基烷基;R2从以下组中选择:可选择取代的芳基或可选择取代的杂芳基或NR7R8;R3、R4、R5、R6、R7和R8如本文所定义;并提供n=1或2。还提供了包含这些化合物的药物组合物。这些化合物在治疗各种病症,包括心律失常方面具有用途。